- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Felodipine sustained-release tablets are used to treat hypertension and stable angina pectoris.
According to our latest study, the global Felodipine Sustained-Release Tablet market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Felodipine Sustained-Release Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Felodipine Sustained-Release Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Felodipine Sustained-Release Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Felodipine Sustained-Release Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Felodipine Sustained-Release Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Felodipine Sustained-Release Tablet
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Felodipine Sustained-Release Tablet market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon and Changzhou Siyao Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Felodipine Sustained-Release Tablet market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2.5mg Per Tablet
5mg Per Tablet
Others
Market segment by Application
Treat High Blood Pressure
Relieve Angina
Others
Major players covered
Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Felodipine Sustained-Release Tablet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Felodipine Sustained-Release Tablet, with price, sales, revenue and global market share of Felodipine Sustained-Release Tablet from 2018 to 2023.
Chapter 3, the Felodipine Sustained-Release Tablet competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Felodipine Sustained-Release Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Felodipine Sustained-Release Tablet market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Felodipine Sustained-Release Tablet.
Chapter 14 and 15, to describe Felodipine Sustained-Release Tablet sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Felodipine Sustained-Release Tablet
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Felodipine Sustained-Release Tablet Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 2.5mg Per Tablet
1.3.3 5mg Per Tablet
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Felodipine Sustained-Release Tablet Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Treat High Blood Pressure
1.4.3 Relieve Angina
1.4.4 Others
1.5 Global Felodipine Sustained-Release Tablet Market Size & Forecast
1.5.1 Global Felodipine Sustained-Release Tablet Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Felodipine Sustained-Release Tablet Sales Quantity (2018-2029)
1.5.3 Global Felodipine Sustained-Release Tablet Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca Felodipine Sustained-Release Tablet Product and Services
2.1.4 Astrazeneca Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Astrazeneca Recent Developments/Updates
2.2 NanJing Easeheal Phaemaecutical
2.2.1 NanJing Easeheal Phaemaecutical Details
2.2.2 NanJing Easeheal Phaemaecutical Major Business
2.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product and Services
2.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 NanJing Easeheal Phaemaecutical Recent Developments/Updates
2.3 SHANXI KANGBO BIOLOGICAL PRODUCT
2.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Details
2.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
2.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product and Services
2.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
2.4 Lifeon
2.4.1 Lifeon Details
2.4.2 Lifeon Major Business
2.4.3 Lifeon Felodipine Sustained-Release Tablet Product and Services
2.4.4 Lifeon Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lifeon Recent Developments/Updates
2.5 Changzhou Siyao Pharmaceutical
2.5.1 Changzhou Siyao Pharmaceutical Details
2.5.2 Changzhou Siyao Pharmaceutical Major Business
2.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product and Services
2.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Felodipine Sustained-Release Tablet Product and Services
2.6.4 Mylan Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mylan Recent Developments/Updates
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Felodipine Sustained-Release Tablet Product and Services
2.7.4 Sandoz Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sandoz Recent Developments/Updates
3 Competitive Environment: Felodipine Sustained-Release Tablet by Manufacturer
3.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Manufacturer (2018-2023)
3.2 Global Felodipine Sustained-Release Tablet Revenue by Manufacturer (2018-2023)
3.3 Global Felodipine Sustained-Release Tablet Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Felodipine Sustained-Release Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2022
3.4.2 Top 6 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2022
3.5 Felodipine Sustained-Release Tablet Market: Overall Company Footprint Analysis
3.5.1 Felodipine Sustained-Release Tablet Market: Region Footprint
3.5.2 Felodipine Sustained-Release Tablet Market: Company Product Type Footprint
3.5.3 Felodipine Sustained-Release Tablet Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Felodipine Sustained-Release Tablet Market Size by Region
4.1.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Region (2018-2029)
4.1.2 Global Felodipine Sustained-Release Tablet Consumption Value by Region (2018-2029)
4.1.3 Global Felodipine Sustained-Release Tablet Average Price by Region (2018-2029)
4.2 North America Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
4.3 Europe Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
4.4 Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
4.5 South America Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
4.6 Middle East and Africa Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
5.2 Global Felodipine Sustained-Release Tablet Consumption Value by Type (2018-2029)
5.3 Global Felodipine Sustained-Release Tablet Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
6.2 Global Felodipine Sustained-Release Tablet Consumption Value by Application (2018-2029)
6.3 Global Felodipine Sustained-Release Tablet Average Price by Application (2018-2029)
7 North America
7.1 North America Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
7.2 North America Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
7.3 North America Felodipine Sustained-Release Tablet Market Size by Country
7.3.1 North America Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
7.3.2 North America Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
8.2 Europe Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
8.3 Europe Felodipine Sustained-Release Tablet Market Size by Country
8.3.1 Europe Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
8.3.2 Europe Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Region
9.3.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
10.2 South America Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
10.3 South America Felodipine Sustained-Release Tablet Market Size by Country
10.3.1 South America Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
10.3.2 South America Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Felodipine Sustained-Release Tablet Market Size by Country
11.3.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Felodipine Sustained-Release Tablet Market Drivers
12.2 Felodipine Sustained-Release Tablet Market Restraints
12.3 Felodipine Sustained-Release Tablet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Felodipine Sustained-Release Tablet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Felodipine Sustained-Release Tablet
13.3 Felodipine Sustained-Release Tablet Production Process
13.4 Felodipine Sustained-Release Tablet Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Felodipine Sustained-Release Tablet Typical Distributors
14.3 Felodipine Sustained-Release Tablet Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Felodipine Sustained-Release Tablet Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Felodipine Sustained-Release Tablet Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 4. Astrazeneca Major Business
Table 5. Astrazeneca Felodipine Sustained-Release Tablet Product and Services
Table 6. Astrazeneca Felodipine Sustained-Release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Astrazeneca Recent Developments/Updates
Table 8. NanJing Easeheal Phaemaecutical Basic Information, Manufacturing Base and Competitors
Table 9. NanJing Easeheal Phaemaecutical Major Business
Table 10. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product and Services
Table 11. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. NanJing Easeheal Phaemaecutical Recent Developments/Updates
Table 13. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Manufacturing Base and Competitors
Table 14. SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
Table 15. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product and Services
Table 16. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
Table 18. Lifeon Basic Information, Manufacturing Base and Competitors
Table 19. Lifeon Major Business
Table 20. Lifeon Felodipine Sustained-Release Tablet Product and Services
Table 21. Lifeon Felodipine Sustained-Release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lifeon Recent Developments/Updates
Table 23. Changzhou Siyao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Changzhou Siyao Pharmaceutical Major Business
Table 25. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product and Services
Table 26. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Changzhou Siyao Pharmaceutical Recent Developments/Updates
Table 28. Mylan Basic Information, Manufacturing Base and Competitors
Table 29. Mylan Major Business
Table 30. Mylan Felodipine Sustained-Release Tablet Product and Services
Table 31. Mylan Felodipine Sustained-Release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Mylan Recent Developments/Updates
Table 33. Sandoz Basic Information, Manufacturing Base and Competitors
Table 34. Sandoz Major Business
Table 35. Sandoz Felodipine Sustained-Release Tablet Product and Services
Table 36. Sandoz Felodipine Sustained-Release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sandoz Recent Developments/Updates
Table 38. Global Felodipine Sustained-Release Tablet Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Felodipine Sustained-Release Tablet Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Felodipine Sustained-Release Tablet Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Felodipine Sustained-Release Tablet, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Felodipine Sustained-Release Tablet Production Site of Key Manufacturer
Table 43. Felodipine Sustained-Release Tablet Market: Company Product Type Footprint
Table 44. Felodipine Sustained-Release Tablet Market: Company Product Application Footprint
Table 45. Felodipine Sustained-Release Tablet New Market Entrants and Barriers to Market Entry
Table 46. Felodipine Sustained-Release Tablet Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Felodipine Sustained-Release Tablet Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Felodipine Sustained-Release Tablet Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Felodipine Sustained-Release Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Felodipine Sustained-Release Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Felodipine Sustained-Release Tablet Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Felodipine Sustained-Release Tablet Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Felodipine Sustained-Release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Felodipine Sustained-Release Tablet Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Felodipine Sustained-Release Tablet Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Felodipine Sustained-Release Tablet Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Felodipine Sustained-Release Tablet Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Felodipine Sustained-Release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Felodipine Sustained-Release Tablet Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Felodipine Sustained-Release Tablet Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Felodipine Sustained-Release Tablet Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Felodipine Sustained-Release Tablet Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Felodipine Sustained-Release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Felodipine Sustained-Release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Felodipine Sustained-Release Tablet Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Felodipine Sustained-Release Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Felodipine Sustained-Release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Felodipine Sustained-Release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Felodipine Sustained-Release Tablet Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Felodipine Sustained-Release Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Felodipine Sustained-Release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Felodipine Sustained-Release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Felodipine Sustained-Release Tablet Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Felodipine Sustained-Release Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Felodipine Sustained-Release Tablet Raw Material
Table 106. Key Manufacturers of Felodipine Sustained-Release Tablet Raw Materials
Table 107. Felodipine Sustained-Release Tablet Typical Distributors
Table 108. Felodipine Sustained-Release Tablet Typical Customers
List of Figures
Figure 1. Felodipine Sustained-Release Tablet Picture
Figure 2. Global Felodipine Sustained-Release Tablet Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Felodipine Sustained-Release Tablet Consumption Value Market Share by Type in 2022
Figure 4. 2.5mg Per Tablet Examples
Figure 5. 5mg Per Tablet Examples
Figure 6. Others Examples
Figure 7. Global Felodipine Sustained-Release Tablet Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Felodipine Sustained-Release Tablet Consumption Value Market Share by Application in 2022
Figure 9. Treat High Blood Pressure Examples
Figure 10. Relieve Angina Examples
Figure 11. Others Examples
Figure 12. Global Felodipine Sustained-Release Tablet Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Felodipine Sustained-Release Tablet Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Felodipine Sustained-Release Tablet Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Felodipine Sustained-Release Tablet Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Felodipine Sustained-Release Tablet Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Felodipine Sustained-Release Tablet Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Felodipine Sustained-Release Tablet by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Felodipine Sustained-Release Tablet Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Felodipine Sustained-Release Tablet Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Felodipine Sustained-Release Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Felodipine Sustained-Release Tablet Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Felodipine Sustained-Release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Felodipine Sustained-Release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Felodipine Sustained-Release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Felodipine Sustained-Release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Felodipine Sustained-Release Tablet Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Felodipine Sustained-Release Tablet Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Felodipine Sustained-Release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Felodipine Sustained-Release Tablet Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Felodipine Sustained-Release Tablet Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Felodipine Sustained-Release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Felodipine Sustained-Release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Felodipine Sustained-Release Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Felodipine Sustained-Release Tablet Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Felodipine Sustained-Release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Felodipine Sustained-Release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Felodipine Sustained-Release Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Felodipine Sustained-Release Tablet Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value Market Share by Region (2018-2029)
Figure 54. China Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Felodipine Sustained-Release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Felodipine Sustained-Release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Felodipine Sustained-Release Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Felodipine Sustained-Release Tablet Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Felodipine Sustained-Release Tablet Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Felodipine Sustained-Release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Felodipine Sustained-Release Tablet Market Drivers
Figure 75. Felodipine Sustained-Release Tablet Market Restraints
Figure 76. Felodipine Sustained-Release Tablet Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet in 2022
Figure 79. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
Figure 80. Felodipine Sustained-Release Tablet Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
